AVRA SYNTHESIS PVT LTD

Company Introduction

Avra Synthesis Pvt. Ltd. is an Indian company based in Hyderabad, specializing in Contract Research and Manufacturing Services (CRAMS) for the global pharmaceutical, agrochemical, and specialty chemical industries. Founded by Dr. A.V. Rama Rao, a distinguished synthetic organic chemist, the company excels in process development, custom synthesis, and the manufacturing of advanced intermediates, Active Pharmaceutical Ingredients (APIs), and specialty chemicals. Avra Synthesis offers comprehensive solutions ranging from gram-scale laboratory synthesis to multi-ton commercial production, supported by its strong capabilities in synthetic organic chemistry. The company is committed to delivering high-quality products and services while adhering to stringent regulatory and quality standards. Its integrated facilities include modern research and development laboratories and manufacturing plants designed to meet diverse client needs.

Factory or Trader

Factory.

AVRA SYNTHESIS PVT LTD manufactures and sells a diverse range of products, primarily in the pharmaceutical and chemical sectors. These include:

Active Pharmaceutical Ingredients (APIs)

The company produces a broad portfolio of APIs, particularly focusing on new generation molecules across various therapeutic areas such as diabetes, cardiovascular diseases, oncology, and immunology.

Examples: Dapagliflozin, Empagliflozin, Ticagrelor, Rivaroxaban, Tofacitinib, Enzalutamide, Palbociclib, Olaparib, Imatinib, Erlotinib, Osimertinib.

Pharmaceutical Intermediates

These are key chemical building blocks and advanced intermediates essential for the synthesis of Active Pharmaceutical Ingredients. Avra Synthesis often provides custom synthesis of these intermediates to meet specific client requirements.

Specialty Chemicals

The company also engages in custom manufacturing and synthesis of various specialty chemicals. These are tailored for specific industrial applications and often involve complex organic chemistry processes.